Cytokinetics Inc. (CYTK)

$ 62.58
   
  • Change Today:
    $0.00
  • 52 Week High: $68.15
  • 52 Week Low: $29.84
  • Currency: US Dollars
  • Shares Issued: 55.37m
  • Volume: 1,234,063
  • Market Cap: $3,465.25m
  • RiskGrade: 332

CYTK Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

CYTK Fundamentals

Fundamentals data is not available for this company.

CYTK Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 142.61 (667.27) (500.52)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 399.37 (472.63) (352.06)¢ n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

CYTK ShareCast News

No recent information was found.

CYTK Top Newspaper Links

Amgen picks up new heart drug 28-May-2009 Chicago Tribune
Amgen pays $50 million for rights to heart drug 27-May-2009 LA Times
A Tough Quarter for Some Drug Makers 26-Jan-2007 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

CYTK Market Data

Currency US Dollars
Share Price $ 62.58
Change Today $ 0.00
% Change 0.00 %
52 Week High $68.15
52 Week Low $29.84
Volume 1,234,063
Shares Issued 55.37m
Market Cap $3,465.25m
RiskGrade 332

What The Brokers Say

Strong Buy 3
Buy 13
Neutral 4
Sell 0
Strong Sell 0
Total 20
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page